concentr
ugrnl
neither
amphotericin
b
deoxychol
inactiv
effect
upon
transmiss
gastroenter
coronaviru
infect
howev
amphothericin
b
stimul
plaqu
formatin
agaros
facilit
entri
viral
rna
swine
testi
cell
combin
amphotericin
b
deoxychol
inactiv
viru
infect
induc
decreas
plaqu
diamet
final
presenc
agent
product
infecti
viru
interferon
unchang
fongizon
clinic
formul
amphotericin
b
amb
combin
deoxychol
doc
stabil
wide
use
antifung
agent
antivir
effect
amb
result
alter
viral
envelop
combin
sterol
compon
also
enhanc
interferon
ifn
product
host
cell
human
coronaviru
found
inactiv
amb
hand
amb
reportedli
enhanc
viral
rna
infect
sinc
cell
cultur
virolog
studi
often
requir
antibiot
prevent
fungu
contamin
aim
clarifi
effect
compound
name
fongizion
amb
doc
upon
viru
infect
use
transmiss
gastroenter
coronaviru
toev
submit
septemb
accept
march
present
address
nation
institut
veterinari
research
nga
tu
vongdong
da
hanoi
vietnam
correspond
address
chemic
fongizon
biopro
mulhous
franc
use
indic
supplier
state
deliveri
arnb
sigma
mo
usa
dissolv
ethanol
use
immedi
doc
sigma
deaedextran
purchas
pharmacia
w
proteinas
k
boehring
mannheim
western
germani
dissolv
l
mgrnl
distil
water
kept
cell
viru
toev
strai
ns
purdueu
well
swine
testi
st
pig
kidney
rpd
cell
line
describ
elsewher
viru
stock
prepar
grow
toev
rpd
cell
plaqu
assay
toey
carri
confluent
monolay
st
cell
plastic
plate
costar
also
describ
effect
fongizon
arnb
doc
toev
prepar
x
pfu
per
ml
appropri
concentr
compound
desir
time
incub
volum
prepar
remov
inocul
onto
confluent
monolay
cell
follow
viruscel
incub
h
inocula
remov
wash
minim
essenti
medium
mem
agaroseoverlay
medium
without
serum
replac
plaqu
format
viru
suspens
treat
mem
andor
ethanol
concentr
use
arnbtreat
viru
suspens
serv
control
plaqu
size
number
also
record
compound
ad
agaroseoverlay
medium
without
serum
studi
eff
ect
viru
attach
ifn
titrat
confluent
monolay
cell
plate
infect
toev
moi
pfu
per
cell
inocula
remov
h
incub
fongizon
andor
arnb
differ
concentr
mem
without
bovin
fcetal
serum
replac
viru
harvest
h
postinocul
titrat
ifn
viru
su
spension
also
titrat
tgevrna
infect
viru
purif
phenol
extract
tgevrna
perform
accord
method
describ
brian
et
precipit
viral
rna
dilut
te
buffer
mm
trishci
mm
edta
ph
obtain
initi
viru
volum
ml
viru
titr
pfurnl
test
infect
rna
solut
serial
two
fold
dilut
follow
solut
mem
memdeaedextran
ugrnl
mem
deaedextranamb
ugml
memdeaedextranfongizon
ugml
memamb
mem
fongizon
rna
dilut
inocul
cell
grown
confluent
monolay
plastic
plate
costar
cell
observ
daili
follow
day
frozen
thaw
twice
presenc
toev
sought
identifi
seroneutr
test
use
specif
antibodi
previou
studi
preliminari
studi
effect
upon
tgev
infect
either
amb
doc
separ
found
concentr
flgml
experi
use
concentr
ugml
amb
doc
alon
toev
infect
decreas
function
incub
time
similar
control
howev
presenc
fongizon
amb
plu
doc
decreas
toev
infect
clearli
differ
control
fig
suggest
amb
doc
virusinactiv
effect
combin
addit
fongizon
combin
amb
plu
doc
agaroverlay
medium
appar
affect
plaqu
number
data
shown
plaqu
size
found
reduc
proport
concentr
fig
differ
plaqu
format
observ
control
experi
use
doc
howev
amb
alon
ad
agaroverlay
medium
enhanc
plaqu
format
enhanc
observ
st
cell
fig
rpd
cell
ethanol
use
dissolv
amb
control
ethanol
ad
agaroverlay
medium
perform
result
variat
plaqu
number
data
shown
amb
fongizon
medium
use
viru
growth
effect
either
viral
yield
ifn
product
indic
similar
viru
ifn
titr
experi
control
data
shown
howev
amb
ad
deaedextran
induc
viru
replic
viral
rna
although
ratio
rna
titr
vs
viru
titr
howev
viru
replic
result
rna
dilut
solut
data
shown
toev
envelop
viru
report
inactiv
doc
concentr
concentr
also
found
doc
inactiv
toev
data
shown
lower
concentr
flgml
doc
inactiv
tobv
infect
concentr
chemic
use
present
studi
flgml
chosen
usual
use
prevent
fungal
contamin
cell
cultur
amb
lower
concentr
flgml
also
inactiv
tobv
infect
howev
amb
doc
combin
found
effect
similar
fongizon
result
consist
observ
devald
et
al
kessler
et
al
result
obtain
jordan
seet
claim
fongizon
concentr
flgml
affect
envelop
viru
infect
howev
kessler
et
al
claim
amb
inactiv
hepat
b
viru
use
fongizon
compound
compris
amb
doc
assum
amb
alter
viral
envelop
creat
pore
similar
treat
eukaryot
cell
membran
howev
alter
suffici
inactiv
viru
infect
doc
requir
complet
inactiv
pore
produc
viceversa
synerg
effect
may
also
mechan
action
two
substanc
toev
known
induc
ifn
studi
ifn
product
found
unchang
addit
fongizon
amb
tabl
therefor
viru
inactiv
explain
enhanc
product
ifn
turn
inactiv
viru
multipl
ad
alon
agaroverlay
arnb
enhanc
plaqu
format
st
cell
enhanc
viru
multipl
indic
similar
viru
titr
presenc
absenc
amb
tabl
along
result
viral
rna
infect
presenc
arnb
suggest
facilit
action
amb
intracellular
penetr
viral
rna
rather
enhanc
synthesi
viral
compon
result
agreement
observ
borden
et
al
final
plaqu
format
enhanc
arnb
st
rpd
cell
recent
studi
publish
found
similar
inocula
toev
induc
plaqu
number
nearli
threefold
higher
st
cell
rpd
cell
independ
viru
strain
use
present
studi
viral
rna
penetr
found
facilit
arnb
therefor
plaqu
observ
st
cell
possibl
similar
reaction
occur
rpd
cell
viru
replic
remain
limit
cell
howev
satisfactori
explan
enhanc
effect
amb
plaqu
format
doc
jointli
ad
explain
contrast
amb
plu
doc
fongizon
agaroverlay
medium
inactiv
toev
therefor
limit
plaqu
size
develop
liquid
mem
use
viru
growth
conclus
amb
doc
found
inactiv
toev
infect
concentr
flgml
alon
concentr
neither
effect
moreov
amb
enhanc
viral
rna
penetr
